Gladstone Michael
- SEC CIK
- 0001864256
No open-market purchases or sales filed in the past year.
Current role at each company
- THRD Third Harmonic Bio, Inc.Director, 10% Owneras of Aug 14, 2025
- DAWN Day One Biopharmaceuticals, Inc.Directoras of May 28, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Gladstone Michael as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DAWN Day One Biopharmaceuticals, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 22, 2022 (view filing) | Jun 17 | 5 days | Gladstone MichaelDirector | PPurchase | +766.7K | $15.00 | +$11.5M | New position766.7K after |